Macquarie Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,261
Closed -$37 2594
2022
Q1
$37 Hold
2,261
﹤0.01% 2243
2021
Q4
$107K Hold
2,261
﹤0.01% 1921
2021
Q3
$164K Hold
2,261
﹤0.01% 1840
2021
Q2
$190K Buy
+2,261
New +$149K ﹤0.01% 1814

Other funds holding NBP

Macquarie Group's NBP Position: Q2 2022 in Review

Macquarie Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 2,261 shares — an estimated $37 sold.

Macquarie Group first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $190K in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Macquarie Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Macquarie Group sold 2,261 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $37.
  • Macquarie Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
  • Macquarie Group's NovaBridge Biosciences American Depositary Shares position peaked at $190K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.